147 related articles for article (PubMed ID: 35912845)
1. The impact of sepsis on hepatic drug metabolism in critically ill patients: a narrative review.
Ewoldt TM; Abdulla A; Hunfeld N; Li L; Smeets TJL; Gommers D; Koch BCP; Endeman H
Expert Opin Drug Metab Toxicol; 2022 Jun; 18(6):413-421. PubMed ID: 35912845
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.
De Paepe P; Belpaire FM; Buylaert WA
Clin Pharmacokinet; 2002; 41(14):1135-51. PubMed ID: 12405864
[TBL] [Abstract][Full Text] [Related]
3. Physiological changes in the critically ill patient with sepsis.
Hosein S; Udy AA; Lipman J
Curr Pharm Biotechnol; 2011 Dec; 12(12):1991-5. PubMed ID: 21554219
[TBL] [Abstract][Full Text] [Related]
4. Drug absorption, distribution, metabolism and excretion considerations in critically ill adults.
Roberts DJ; Hall RI
Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1067-84. PubMed ID: 23682923
[TBL] [Abstract][Full Text] [Related]
5. Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients.
Radke C; Horn D; Lanckohr C; Ellger B; Meyer M; Eissing T; Hempel G
Clin Pharmacokinet; 2017 Jul; 56(7):759-779. PubMed ID: 28039606
[TBL] [Abstract][Full Text] [Related]
6. Feeding the critically ill obese patient: a systematic review protocol.
Secombe P; Harley S; Chapman M; Aromataris E
JBI Database System Rev Implement Rep; 2015 Oct; 13(10):95-109. PubMed ID: 26571286
[TBL] [Abstract][Full Text] [Related]
7. High-volume haemofiltration for sepsis in adults.
Borthwick EM; Hill CJ; Rabindranath KS; Maxwell AP; McAuley DF; Blackwood B
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD008075. PubMed ID: 28141912
[TBL] [Abstract][Full Text] [Related]
8. Hepatic drug metabolism in critical illness.
McKindley DS; Hanes S; Boucher BA
Pharmacotherapy; 1998; 18(4):759-78. PubMed ID: 9692650
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers Predicting Tissue Pharmacokinetics of Antimicrobials in Sepsis: A Review.
Sanz Codina M; Zeitlinger M
Clin Pharmacokinet; 2022 May; 61(5):593-617. PubMed ID: 35218003
[TBL] [Abstract][Full Text] [Related]
10. Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis.
Fujii T; Ganeko R; Kataoka Y; Furukawa TA; Featherstone R; Doi K; Vincent JL; Pasero D; Robert R; Ronco C; Bagshaw SM
Intensive Care Med; 2018 Feb; 44(2):167-178. PubMed ID: 29204670
[TBL] [Abstract][Full Text] [Related]
11. Polymyxin B-immobilised haemoperfusion and mortality in critically ill patients with sepsis/septic shock: a protocol for a systematic review and meta-analysis.
Fujii T; Ganeko R; Kataoka Y; Featherstone R; Bagshaw SM; Furukawa TA
BMJ Open; 2016 Nov; 6(11):e012908. PubMed ID: 27872122
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis.
Turgeon AF; Hutton B; Fergusson DA; McIntyre L; Tinmouth AA; Cameron DW; Hébert PC
Ann Intern Med; 2007 Feb; 146(3):193-203. PubMed ID: 17283351
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin Pharmacokinetics in Obese Patients with Sepsis or Septic Shock.
Masich AM; Kalaria SN; Gonzales JP; Heil EL; Tata AL; Claeys KC; Patel D; Gopalakrishnan M
Pharmacotherapy; 2020 Mar; 40(3):211-220. PubMed ID: 31957057
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis.
Soares MO; Welton NJ; Harrison DA; Peura P; Shankar- Hari M; Harvey SE; Madan JJ; Ades AE; Palmer SJ; Rowan KM
Health Technol Assess; 2012; 16(7):1-186. PubMed ID: 22361003
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock.
Varghese JM; Roberts JA; Lipman J
Crit Care Clin; 2011 Jan; 27(1):19-34. PubMed ID: 21144984
[TBL] [Abstract][Full Text] [Related]
16. Use of intravenous lipids in critically ill patients with sepsis without and with hepatic failure.
Druml W; Fischer M; Ratheiser K
JPEN J Parenter Enteral Nutr; 1998; 22(4):217-23. PubMed ID: 9661122
[TBL] [Abstract][Full Text] [Related]
17. Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?
Roberts JA; Roberts MS; Robertson TA; Dalley AJ; Lipman J
Crit Care Med; 2009 Mar; 37(3):926-33. PubMed ID: 19237898
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal disorders of the critically ill. Shock liver.
Strassburg CP
Best Pract Res Clin Gastroenterol; 2003 Jun; 17(3):369-81. PubMed ID: 12763502
[TBL] [Abstract][Full Text] [Related]
19. Key Challenges in Providing Effective Antibiotic Therapy for Critically Ill Patients with Bacterial Sepsis and Septic Shock.
Landersdorfer CB; Nation RL
Clin Pharmacol Ther; 2021 Apr; 109(4):892-904. PubMed ID: 33570163
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics and Monte Carlo dosing simulations of meropenem during the early phase of severe sepsis and septic shock in critically ill patients in intensive care units.
Jaruratanasirikul S; Thengyai S; Wongpoowarak W; Wattanavijitkul T; Tangkitwanitjaroen K; Sukarnjanaset W; Jullangkoon M; Samaeng M
Antimicrob Agents Chemother; 2015; 59(6):2995-3001. PubMed ID: 25753628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
